Safe Group announces the opening of rehabilitation proceedings
06 9월 2023 - 3:30PM
Safe Group announces the opening of rehabilitation proceedings
Safe Group announces the opening of
rehabilitation
proceedings |
|
|
|
Éragny-sur-Oise,
Fleurieux sur
l’Arbresle, France, on
6 September at
08h30 CET – Safe (FR001400F1V2 –
ALSAF), French group specialized in the design, manufacturing and
distribution of ready-to-use medical devices for Spine surgeries,
especially safe for vertebral fracture treated in emergency,
announces the opening of rehabilitation proceedings.
Following the press release of July 28, 2023
announcing the suspension of the financing agreement with ABO and
the Group's decision to file a petition before the Commercial Court
of Pontoise for the opening of a rehabilitation proceedings, the
said court, by judgments dated September 4, 2023, ordered the
opening of rehabilitation proceedings with regard to SAFE SA and
its French subsidiaries (SAFE ORTHOPAEDICS SAS and SAFE MEDICAL
SAS), providing a 6-months observation period, and appointed SELARL
BLERIOT & Associés, in the person of Maître Philippe Blériot,
as Judicial Administrator. . In accordance with the provisions of
article L. 631-15 of the French Commercial Code, the Commercial
Court shall consider the opportunity to continue the observation
period within two months of the opening judgment. Rehabilitation
proceeding initiated in respect of the SAFE Group companies will
thus be examined by the Commercial Court of Pontoise, at an interim
review hearing on November 17, 2023.
As a reminder, rehabilitation proceedings are
designed to "enable the company to continue to operate the
business, maintain the employment and pay off its liabilities"
(article L.631-1 of the French Commercial Code).
By filing for the Commercial Court of Pontoise
protection, the SAFE Group will aim to pursue the restructuring
initiated since the beginning of 2023, and to rebuild its
short-term cash position in order to seek long-term financing
solutions, as part of a plan to continue its commercial and
technological activities.
Pierre Dumouchel, Chairman and CEO, comments:
"Following our application to the Pontoise Commercial Court, the
rehabilitation proceedings was received on Monday. We will be
working actively with the Court-appointed Administrator to draw up
a plan for staggering and repaying our debts. In the coming weeks
and months, our priorities will remain to support our customers and
seek financing or strategic partnerships to ensure the long-term
future of our Group”.
The SAFE Group also draw the attention of its shareholders to
the fact that, given its financial situation, the proceeds of the
sale received in the context of the current proceedings will not
produce any liquidity for the said shareholders.
Information will be regularly communicated as the receivership
proceedings progress.
About Safe Group
Safe Group is a French medical technology group
that brings together Safe Orthopaedics, a pioneer in ready-to-use
technologies for spine pathologies, and Safe Medical (formerly LCI
Medical), a medical device subcontractor for orthopedic surgeries.
The group employs approximately 125 people.
Safe Orthopaedics develops and manufactures kits
combining sterile implants and ready-to-use instruments, available
at any time to the surgeon. These technologies are part of a
minimally invasive approach aimed at reducing the risks of
contamination and infection, in the interest of the patient and
with a positive impact on hospitalization times and costs.
Protected by 15 patent families, SteriSpineTM kits are CE marked
and FDA approved. Safe Orthopaedics is headquartered in the Paris
region (95610 Eragny-sur-Oise) and has subsidiaries in the United
Kingdom, Germany, the United States, and the Lyon region
(Fleurieux-sur-l'Arbresle).
For more information:
http://www.safeorthopaedics.com/
Safe Medical produces implantable medical
devices and ready-to-use instruments. It has an innovation center
and two production sites in France (Fleurieux-sur-l'Arbresle,
69210) and in Tunisia, offering numerous industrial services:
industrialization, machining, finishing and sterile packaging.
For more information:
http://www.safemedical.fr/
Contacts Safe
Group François-Henri
Reynaud
Chief
Financial and Administrative Officer
Tél.
: +33 (0)1 34 21 50
00 investors@safeorthopaedics.com
- 20230905 - PR RJ vEng revue vDef
Safe Orthopaedics (LSE:0RAA)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Safe Orthopaedics (LSE:0RAA)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025